The FTC
Crackdown Is Real
The Federal Trade Commission has charged
the marketers of a dietary supplement called Coral Calcium Supreme with making false
and unsubstantiated claims about the product's health benefits.
This action is part of a series of
initiatives the FTC and the Food and Drug Administration (FDA) are taking against
the purveyors of products with unsubstantiated health and medical claims.
In a complaint filed in federal district
court, the FTC alleges that Kevin Trudeau; Robert Barefoot; Shop America (USA), LLC;
and Deonna Enterprises, Inc., violated the FTC Act by claiming, falsely and without
substantiation, that Coral Calcium Supreme can treat or cure cancer and other
diseases, such as multiple sclerosis and heart disease. The FTC charges that
these and other claims go far beyond existing scientific evidence regarding the
recognized health benefits of calcium.
In a separate action, the FTC has
charged one of the defendants, Kevin Trudeau, with violating a 1998 federal
district court order that prohibits him from making unsubstantiated claims about the
benefits, performance, or efficacy of any products.
The FTC alleges that Trudeau violated
that order by making false and unsubstantiated claims about Coral Calcium Supreme,
and by making unsubstantiated claims that another product, Biotape, provides
significant or permanent relief from severe pain, including debilitating back pain,
and pain from arthritis, sciatica, and migraines.
In both of these actions, the FTC has
asked the court for a temporary restraining order that would prohibit the defendants
from making the challenged claims and would freeze their
assets.
In related law enforcement efforts, the
FTC and the FDA are sending strong warning letters to Web site operators who are
marketing coral calcium products claiming that coral calcium is an effective
treatment or cure for cancer and/or other diseases.
In dozens of warnings sent this week,
the FTC states it is aware of no competent and reliable scientific evidence
supporting such claims and that such unsupported claims are unlawful under the FTC
Act.
Accordingly, the FTC is instructing the
Web site operators to remove any false or deceptive claims from their sites
immediately. In a similar action, the FDA warned Web site operators that
disease claims and unsubstantiated structure/function claims cause their products
to be in violation of the Federal Food, Drug, and Cosmetic Act.
Lawsuit
Information and Asset Protection is Needed More Now than Ever Before.
"FDA and FTC are working together to
maximize our efforts to combat health fraud," said FDA Commissioner Mark B. McCellan.
"We are trying to be particularly vigilant concerning fraudulent internet
promotion, because this is emerging as an increasingly insidious way of trying to
exploit the public."
The FTC and FDA had conducted Internet
"surfs" and found numerous Web sites touting coral calcium products as an effective
treatment or cure for cancer and other diseases such as lupus, multiple sclerosis,
and heart disease. The staffs of the two agencies will follow up by revisiting
the target sites to determine whether the Web site operators gave deleted or revised
the unproven claims.
The FTC vote to authorize filing of the
cases was 5-0. The cases were filed in the U.S. District Court for the Northern
District of Illinois, Eastern Division, on June 9, 2003.
Reference: http://www.ftc.gov/opa/2003/06/trudeau.htm
The FTC can and
will freeze assets under such investigations as the above article depicted.
This not only involves the owners, but all who market such Internet Business
Opportunities as affiliates. Which company will be sued next? Don't
take needless risks.
|